Abstract

Sasbou Lamyae*, Boussima Hanane, El Gueddar F. Z., Barsoum Mikhail Paul, Maroni Jean Pierre

ABSTRACT

Cardiac sarcoidosis is a manifestation of sarcoidosis that is challenging to diagnose due to its clinical silence, but its identification is vitally important, as its repercussions are potentially devastating. These repercussions include conduction abnormalities, arrhythmias, cardiomyopathy, congestive heart failure and sudden cardiac death. This case describes a 40-year-old indian female with a atrio ventricular block and a dilated cardiomyopathy who had a delayed diagnosis of sarcoidosis with cardiac involvement. It was later deemed to be cardiac sarcoidosis after the onset of PET scan, cardiac MRI and biological elements. Treatment focuses on optimising heart failure therapy, placement of a biventricular implantable cardioverter defibrillator for primary prevention of sudden cardiac death and glucocorticoid. Although some studies suggest a potential benefit from glucocorticoid therapy, conclusive evidence revealing the true value of this treatment regimen has yet to be determined.